MarketsstocksAI Generated

BioNTech Names Guido Oelkers as New Chief Executive Officer

By rawfin.tv Markets Desk|August 23, 2026, 02:24 UTC|1 min read|AI-assisted · Methodology

BioNTech SE has announced the appointment of Guido Oelkers, Ph.D., as its new Chief Executive Officer, with his tenure commencing on February 1, 2027. Oelkers will succeed current CEO Ugur Sahin, marking a significant leadership transition for the biotechnology firm.

biotechCEO-changecorporate-newspharmaceuticals

BioNTech Names Guido Oelkers as New Chief Executive Officer

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

EQT to Acquire Cleanaway Waste for $6.5 Billion

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008